According to the characteristics of drugs and development plans, we match more suitable leading PIs, leading sites, investigators, and sub-centers by taking into account the academic influence, project competitiveness, and experience in large-scale clinical trials. We explore and expand patient recruitment sources through multiple channels, comprehensively control project quality management and risks, and assist the quick application to authorities for the products.
Copyright © 2019-2025 Shanghai UnionClin Pharmaceutical Technology Co., Ltd. 沪ICP备18015058号-3 沪公网安备31011502403127号 Powered by PAIKY Network.
